Search Within

Ellen Marlese Basu

  1. "Neeta Pandit-Taskar"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (5)
Groups
  1. Molecular Imaging and Therapy Service (17)
  2. Neuroblastoma Service (17)
  3. Pediatrics, Department of (17)
  4. Radiology, Department of (17)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (12)
  6. GSK Faculty (12)

More Groups

People
  1. Neeta Pandit-Taskar (17)
  2. Shakeel Modak (15)
  3. Nai-Kong Cheung (12)
  4. Brian Kushner (11)
  5. Kim Kramer (9)
  6. Stephen Roberts (8)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (4)
  4. 2022 (1)
  5. 2020 (1)
  6. 2019 (3)

More Years

Publications
  1. Pediatric Blood and Cancer (7)
  2. Journal of Clinical Oncology (3)
  3. Neuro-Oncology (3)
  4. EJNMMI Research (1)
  5. Journal of Neuro-Oncology (1)
  6. Journal of Nuclear Medicine (1)

More Publications

Publishers
  1. Wiley Periodicals, Inc (7)
  2. American Society of Clinical Oncology (3)
  3. Oxford University Press (3)
  4. Springer (2)
  5. Lippincott Williams & Wilkins (1)
  6. Society of Nuclear Medicine (1)

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety observations in neuroblastoma patients undergoing (18)F- mFBG PET
    Journal Article

    Pandit-Taskar, N.; Basu, E.; Balquin, E.; Mozley, P. D.; Jacobson, A. F.; Modak, S.
    Nuclear Medicine Communications (2025)

    Fulltext@MSK | Save
  • MRI compared to (123)I-MIBG scan for detection of central nervous system relapse in neuroblastoma
    Meeting Abstract

    Stiefel, J.; Kramer, K.; Haque, S.; Basu, E. M.; Kushner, B. H.; Pandit-Taskar, N.; Katz, A.; Cheung, N. K. V.; Modak, S.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with (131)I-omburtamab for leptomeningeal disease
    Journal Article

    Prasad, K.; Serencsits, B. E.; Chu, B. P.; Dauer, L. T.; Donzelli, M.; Basu, E.; Kramer, K.; Pandit-Taskar, N.
    EJNMMI Research (2024)

    Fulltext@MSK | Save
  • 18F-MFBG PET imaging in patients with neuroblastoma: Lesion targeting and comparison with MIBG
    Meeting Abstract

    Pandit-Taskar, N.; Mauguen, A.; Basu, E.; Price, A.; Behr, G.; Min, R.; Lyashchenko, S.; Schwartz, J.; Modak, S.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • (18)F-MFBG PET imaging in patients with neuroblastoma: Lesion targeting and comparison with MIBG
    Meeting Abstract

    Modak, S.; Mauguen, A.; Basu, E. M.; Price, A.; Behr, G.; Min, R.; Lyashchenko, S. K.; Schwartz, J.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma
    Journal Article

    Tringale, K. R.; Wolden, S. L.; Karajannis, M.; Haque, S.; Pasquini, L.; Yildirim, O.; Rosenblum, M.; Benhamida, J. K.; Cheung, N. K.; Souweidane, M.; more...
    Journal of Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma
    Journal Article

    Tringale, K. R.; Wolden, S. L.; Casey, D. L.; Kushner, B. H.; Luo, L.; Pandit-Taskar, N.; Souweidane, M.; Cheung, N. K. V.; Modak, S.; Basu, E. M.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Results of "HITS" phase II study
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Mauguen, A.; Castañeda, A.; Varo, A.; Gorostegui, M.; Muñoz, J. P.; Santa-Maria, V.; Basu, E. M.; Cardenas, F. I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor (GM-CSF) for Resistant Osteomedullary Neuroblastoma: Major Responses and Outpatient Treatment in a Phase II Trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) PLUS stepped-up dosing of granulocyte-macrophage colony-stimulating factor for neuroblastoma: Outpatient treament low immunogenicity, and major responses in a phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save